Reactive vascular lesions treated using ethanolamine oleate sclerotherapy

Dermatologic Surgery

Volumn 36, Issue 7, 2010, Pages 1148-1152

  Hong, Soon Kwon ^a   Lee, Hyun Jae ^a   Seo, Jong Keun ^a   Lee, Deborah ^a   Hwang, Seon Wook ^a   Sung, Ho Suk ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MONOETHANOLAMINE OLEATE; SODIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DILUTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; PAIN; PRIORITY JOURNAL; PYOGENIC GRANULOMA; REMISSION; SCHOOL CHILD; SCLEROTHERAPY; TREATMENT RESPONSE; VASCULAR LESION; VEIN LAKE;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; FEMALE; GRANULOMA, PYOGENIC; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; OLEIC ACIDS; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SKIN DISEASES; TREATMENT OUTCOME; VARICOSE ULCER; YOUNG ADULT;

EID: 77954559754     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01599.x     Document Type: Article

References (27)

1. Muto T, Kinehara M, Takahara M, Sato K. Therapeutic embolization of oral hemangiomas with absolute ethanol. J Oral Maxillofac Surg 1990 48 : 85 8.
2. Van Doorne L, Maeseneer MD, Stricker C, et al. Diagnosis and treatment of vascular lesions of the lip. Br J Oral Maxillofac Surg 2002 40 : 497 503.
3. Mooney MA, Janniger CK. Pyogenic granuloma. Cutis 1995 55 : 133 136.
4. Patrice SJ, Wiss K, Mulliken JB. Pyogenic granuloma(lobulated capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol 1991 8 : 267 276.
5. González S, Vibhagool C, Falo LD Jr., et al. Treatment of pyogenic granulomas with the 585 nm pulsed dye laser. J Am Acad Dermatol 1996 35 : 428 431.
6. Tan OT, Murray S, Kurban AK. Action spectrum of vascular specific injury using pulsed irradiation. J Invest Dermatol 1989 118 : 120 129.
7. Siniluoto TM, Svendsen PA, Wikholm GM, et al. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulfate(Sotradecol). Scand J Plast Reconstr Hand Surg 1997 31 : 145 150.
8. Woods JE. Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions. Plast Reconstr Surg 1987 79 : 542 549.
9. Nishida R, Inoue R, Takimoto Y, Kita T. A sclerosant with astringent properties developed in China for esophageal varices: comparison with ethanolamine oleate and polidocanol. J Gastroenterol Hepatol 1999 14 : 481 488.
10. Sukigara M, Omoto R, Miyamae T. Systemic dissemination of ethanolamine oleate after injection sclerotherapy for esophageal varices. Arch Surg 1985 120 : 833 836.
11. Sakai P, Boaventura S, Capacci ML, et al. Endoscopic sclerotherapy of bleeding esophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis. Endoscopy 1988 20 : 134 136.
12. Neeman A, Leiser A, Kadish U. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate. Am J Gastroenterol 1991 86 : 1182 1184.
13. Meirelles-Santos JO, Carvalho AF Jr., Callejas-Neto F, et al. Absolute ethanol and 5% ethanolamine oleate are comparable for sclerotherapy of esophageal varices. Gastrointest Endosc 2000 51 : 573 576.
14. Winter H, Dräger E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg 2000 26 : 105 108.
15. Baurmash H, Mandel L. The nonsurgical treatment of hemangioma with sotradecol. Oral Surg Oral Med Oral Pathol 1963 16 : 777 782.
16. Chin D. Treatment of maxillary hemangioma with a sclerosing agent. Oral Surg 1983 5 : 247 249.
17. Lorimier AA. Sclerotherapy for venous malformation. J Pediatric Surg 1995 30 : 188 194.
18. Choi YH, Han MH, O-Ki K, et al. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002 13 : 475 482.
19. Sadighi E, Gingrass D. Histopathologic appraisal of an oral hemangioma treated with a sclerosing agent. Compendium 1991 12 : 288 290.
20. Rx list. San Francisco: Neil Sandow; 1994-2003 [update August 20, 2004]. Ethanolamine oleate [on-line]. Available at :. (accessed August, 2004).
21. Matsumoto K, Nakanishi H, Seike T, et al. Treatment of pyogenic granuloma with a sclerosing agent. Dermatol Surg 2001 27 : 521 523.
22. Fishman SJ, Mulliken JB. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Surg 1993 40 : 1177 1200.
23. Drolet BA, Esterly NB, Frieden IJ. Primary care: hemangiomas in children. N Engl J Med 1999 341 : 173 181.
24. Tan Y-K, Weston WL, Morelli JG. Treatment of pyogenic granuloma in children with the flashlamp-pulsed dye laser. Pediatrics 1997 99 : 368 370.
25. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007 26 : 22 8.
26. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988 6 : 340 341.
27. Matsumoto K, Nakanishi H, Koizumi Y, et al. Sclerotherapy of hemangioma with late involution. Dermatol Surg 2003 29 : 668 671.